The FDA approved a new drug to treat one of the most common and deadliest cancer types - lung cancer. An accompanying diagnostic test has been approved to detect patients who may benefit from the immune therapy drug.
The FDA approved a new drug to treat one of the most common and deadliest cancer types - lung cancer. An accompanying diagnostic test has been approved to detect patients who may benefit from the immune therapy drug.
Share this Article
Recommended